Martingale Asset Management’s Oxford Immunotec Global OXFD Stock Holding History
Bought
Maintained
Sold
Other funds holding OXFD
ECM
Martingale Asset Management's OXFD Position: Q4 2019 in Review
Martingale Asset Management sold out of Oxford Immunotec Global (OXFD) in Q4 2019, closing a stake of 17,400 shares — an estimated $290K sold.
Martingale Asset Management first reported a position in OXFD in Q4 2018 and held it in 4 quarters. The position peaked at $2.85M in Q1 2019. 68 funds tracked by Wall St. Rank hold OXFD as of Q4 2019.
- Martingale Asset Management reported no remaining Oxford Immunotec Global position as of Q4 2019 after selling out during the quarter.
- Martingale Asset Management sold 17,400 Oxford Immunotec Global shares in Q4 2019, an estimated $290K.
- Martingale Asset Management first reported a position in Oxford Immunotec Global in Q4 2018 and held it in 4 quarters.
- Martingale Asset Management's Oxford Immunotec Global position peaked at $2.85M in Q1 2019.
- 68 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q4 2019.
Based on Martingale Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.